GDF15 as a biomarker of metabolic dysfunction and mortality in sepsis and ARDS: a cohort study
GDF15 is a biomarker of mitochondrial metabolic dysfunction and is prognostic across three trial populations of sepsis and ARDS, but it was not independently associated with mortality in a smaller observational cohort, and is a candidate for prognostic enrichment in trials of metabolically targeted therapies, though wh...